Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00904878 · ClinicalTrials.gov registry record

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

A clinical trial of Inflammatory Bowel Disease, sponsored by University of California, San Francisco.

Recruiting
Registry status
1,500
Enrollment target
2
Study locations

NCT00904878: Recruiting study of Inflammatory Bowel Disease, sponsored by University of California, San Francisco.

NCT00904878 is a study of Inflammatory Bowel Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,500 participants, above the 350-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (329% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00904878, a study of Inflammatory Bowel Disease, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
1,500 participants
Enrollment target
2
Study locations

Study Summary

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.

Conditions Studied

Inflammatory Bowel Disease

Study Locations (2)

California

  • Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations - San Francisco
  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2007-08
Est. Completion 2028-06
University of California, San Francisco

1,713 total trials

What NCT00904878 shows while recruiting

NCT00904878 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 350-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (329% higher).

The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00904878 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00904878 about?

NCT00904878 is a clinical study titled "A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease". A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is...

What is the current status of trial NCT00904878?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2007-08. Estimated completion is 2028-06.

What conditions does trial NCT00904878 study?

This clinical trial studies the following conditions: Inflammatory Bowel Disease.

Who is sponsoring clinical trial NCT00904878?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00904878 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammatory Bowel Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00904878's enrollment target sits among peer trials

1,500 3rd of 28 higher than 26 of 28 other Inflammatory Bowel Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammatory Bowel Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT00904878

Source: ClinicalTrials.gov NCT00904878, the US trial registry maintained by the National Library of Medicine. NCT00904878 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.